Andrew Gomperts
Gründer bei Hillhurst Biopharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Andrew Gomperts
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Hillhurst Biopharmaceuticals, Inc.
 Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andrew Gomperts
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Chairman | 1 |
| Founder | 1 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Edward Gomperts | 1 |
| Douglas Stockdale | 1 |
| Jeff Friedman | 1 |
- Börse
- Insiders
- Andrew Gomperts
- Unternehmensverbindungen
